Stock-Based Compensation - Â鶹×îгöÆ· - Outstanding Awards (Details) - USD ($) $ / shares in Units, $ in Millions |
12 Months Ended |
Dec. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Total unrecognized compensation cost related to unvested equity awards |
$ 34
|
Ìý
|
Ìý
|
Weighted average period of recognition related to unvested equity awards (in years) |
2 years 1 month 6 days
|
Ìý
|
Ìý
|
Options, exercises in period, total intrinsic value |
$ 163
|
$ 22
|
$ 31
|
Common Class B |
Ìý
|
Ìý
|
Ìý
|
Number of options |
Ìý
|
Ìý
|
Ìý
|
Outstanding at end of period |
0
|
Ìý
|
Ìý
|
Restricted Stock |
Ìý
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Equity instruments other than options, vested in period, fair value |
$ 17
|
$ 9
|
$ 85
|
Â鶹×îгöÆ· Sirius XM Group |
Ìý
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Common stock reserved for issuance |
9,800,000
|
Ìý
|
Ìý
|
Â鶹×îгöÆ· Sirius XM Group | Common Class A |
Ìý
|
Ìý
|
Ìý
|
Number of options |
Ìý
|
Ìý
|
Ìý
|
Outstanding at beginning of period |
1,403,000
|
Ìý
|
Ìý
|
Exercised |
(1,381,000)
|
Ìý
|
Ìý
|
Outstanding at end of period |
22,000
|
1,403,000
|
Ìý
|
Exercisable at end of period |
22,000
|
Ìý
|
Ìý
|
WAEP |
Ìý
|
Ìý
|
Ìý
|
Outstanding at beginning of period |
$ 19.84
|
Ìý
|
Ìý
|
Exercised |
19.79
|
Ìý
|
Ìý
|
Outstanding at end of period |
22.62
|
$ 19.84
|
Ìý
|
Exercisable at end of period |
$ 22.62
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Weighted average remaining life, outstanding |
4 months 24 days
|
Ìý
|
Ìý
|
Weighted average remaining life, exercisable |
4 months 24 days
|
Ìý
|
Ìý
|
Aggregate intrinsic value, outstanding |
$ 1
|
Ìý
|
Ìý
|
Aggregate intrinsic value, exercisable |
$ 1
|
Ìý
|
Ìý
|
Â鶹×îгöÆ· Sirius XM Group | Common Class C |
Ìý
|
Ìý
|
Ìý
|
Number of options |
Ìý
|
Ìý
|
Ìý
|
Outstanding at beginning of period |
11,495,000
|
Ìý
|
Ìý
|
Granted |
1,598,000
|
Ìý
|
Ìý
|
Exercised |
(2,923,000)
|
Ìý
|
Ìý
|
Forfeited/Cancelled |
(353,000)
|
Ìý
|
Ìý
|
Outstanding at end of period |
9,817,000
|
11,495,000
|
Ìý
|
Exercisable at end of period |
7,997,000
|
Ìý
|
Ìý
|
WAEP |
Ìý
|
Ìý
|
Ìý
|
Outstanding at beginning of period |
$ 28.85
|
Ìý
|
Ìý
|
Granted |
45.08
|
Ìý
|
Ìý
|
Exercised |
20.42
|
Ìý
|
Ìý
|
Forfeited/Cancelled |
31.69
|
Ìý
|
Ìý
|
Outstanding at end of period |
33.90
|
$ 28.85
|
Ìý
|
Exercisable at end of period |
$ 32.18
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Weighted average remaining life, outstanding |
3 years 7 months 6 days
|
Ìý
|
Ìý
|
Weighted average remaining life, exercisable |
3 years 2 months 12 days
|
Ìý
|
Ìý
|
Aggregate intrinsic value, outstanding |
$ 140
|
Ìý
|
Ìý
|
Aggregate intrinsic value, exercisable |
$ 128
|
Ìý
|
Ìý
|
Â鶹×îгöÆ· Sirius XM Group | Restricted Stock |
Ìý
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Equity instruments other than options, nonvested, number |
94,000
|
Ìý
|
Ìý
|
Restricted stock weighted average grant-date fair value |
$ 36.07
|
Ìý
|
Ìý
|
Formula One Group |
Ìý
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Common stock reserved for issuance |
8,300,000
|
Ìý
|
Ìý
|
Formula One Group | Common Class A |
Ìý
|
Ìý
|
Ìý
|
Number of options |
Ìý
|
Ìý
|
Ìý
|
Outstanding at beginning of period |
360,000
|
Ìý
|
Ìý
|
Exercised |
(359,000)
|
Ìý
|
Ìý
|
Outstanding at end of period |
1,000
|
360,000
|
Ìý
|
Exercisable at end of period |
1,000
|
Ìý
|
Ìý
|
WAEP |
Ìý
|
Ìý
|
Ìý
|
Outstanding at beginning of period |
$ 11.71
|
Ìý
|
Ìý
|
Exercised |
11.71
|
Ìý
|
Ìý
|
Outstanding at end of period |
12.63
|
$ 11.71
|
Ìý
|
Exercisable at end of period |
$ 12.63
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Weighted average remaining life, outstanding |
3 years
|
Ìý
|
Ìý
|
Weighted average remaining life, exercisable |
3 years
|
Ìý
|
Ìý
|
Formula One Group | Common Class C |
Ìý
|
Ìý
|
Ìý
|
Number of options |
Ìý
|
Ìý
|
Ìý
|
Outstanding at beginning of period |
6,684,000
|
Ìý
|
Ìý
|
Granted |
2,959,000
|
Ìý
|
Ìý
|
Exercised |
(1,273,000)
|
Ìý
|
Ìý
|
Forfeited/Cancelled |
(86,000)
|
Ìý
|
Ìý
|
Outstanding at end of period |
8,284,000
|
6,684,000
|
Ìý
|
Exercisable at end of period |
6,427,000
|
Ìý
|
Ìý
|
WAEP |
Ìý
|
Ìý
|
Ìý
|
Outstanding at beginning of period |
$ 26.92
|
Ìý
|
Ìý
|
Granted |
36.38
|
Ìý
|
Ìý
|
Exercised |
21.80
|
Ìý
|
Ìý
|
Forfeited/Cancelled |
19.26
|
Ìý
|
Ìý
|
Outstanding at end of period |
31.16
|
$ 26.92
|
Ìý
|
Exercisable at end of period |
$ 29.61
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Weighted average remaining life, outstanding |
4 years 10 months 24 days
|
Ìý
|
Ìý
|
Weighted average remaining life, exercisable |
4 years 6 months
|
Ìý
|
Ìý
|
Aggregate intrinsic value, outstanding |
$ 123
|
Ìý
|
Ìý
|
Aggregate intrinsic value, exercisable |
$ 105
|
Ìý
|
Ìý
|
Formula One Group | Restricted Stock |
Ìý
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Equity instruments other than options, nonvested, number |
149,000
|
Ìý
|
Ìý
|
Restricted stock weighted average grant-date fair value |
$ 34.03
|
Ìý
|
Ìý
|
Braves Group |
Ìý
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Common stock reserved for issuance |
1,300,000
|
Ìý
|
Ìý
|
Braves Group | Common Class A |
Ìý
|
Ìý
|
Ìý
|
Number of options |
Ìý
|
Ìý
|
Ìý
|
Outstanding at beginning of period |
177,000
|
Ìý
|
Ìý
|
Exercised |
(175,000)
|
Ìý
|
Ìý
|
Outstanding at end of period |
2,000
|
177,000
|
Ìý
|
Exercisable at end of period |
2,000
|
Ìý
|
Ìý
|
WAEP |
Ìý
|
Ìý
|
Ìý
|
Outstanding at beginning of period |
$ 11.44
|
Ìý
|
Ìý
|
Exercised |
11.43
|
Ìý
|
Ìý
|
Outstanding at end of period |
11.89
|
$ 11.44
|
Ìý
|
Exercisable at end of period |
$ 11.89
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Weighted average remaining life, outstanding |
2 years 6 months
|
Ìý
|
Ìý
|
Weighted average remaining life, exercisable |
2 years 6 months
|
Ìý
|
Ìý
|
Braves Group | Common Class C |
Ìý
|
Ìý
|
Ìý
|
Number of options |
Ìý
|
Ìý
|
Ìý
|
Outstanding at beginning of period |
1,276,000
|
Ìý
|
Ìý
|
Granted |
382,000
|
Ìý
|
Ìý
|
Exercised |
(358,000)
|
Ìý
|
Ìý
|
Forfeited/Cancelled |
(33,000)
|
Ìý
|
Ìý
|
Outstanding at end of period |
1,267,000
|
1,276,000
|
Ìý
|
Exercisable at end of period |
815,000
|
Ìý
|
Ìý
|
WAEP |
Ìý
|
Ìý
|
Ìý
|
Outstanding at beginning of period |
$ 16.58
|
Ìý
|
Ìý
|
Granted |
28.93
|
Ìý
|
Ìý
|
Exercised |
11.37
|
Ìý
|
Ìý
|
Forfeited/Cancelled |
15.19
|
Ìý
|
Ìý
|
Outstanding at end of period |
21.82
|
$ 16.58
|
Ìý
|
Exercisable at end of period |
$ 18.81
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Weighted average remaining life, outstanding |
4 years 3 months 18 days
|
Ìý
|
Ìý
|
Weighted average remaining life, exercisable |
3 years 1 month 6 days
|
Ìý
|
Ìý
|
Aggregate intrinsic value, outstanding |
$ 10
|
Ìý
|
Ìý
|
Aggregate intrinsic value, exercisable |
$ 9
|
Ìý
|
Ìý
|
Braves Group | Restricted Stock |
Ìý
|
Ìý
|
Ìý
|
Additional disclosures |
Ìý
|
Ìý
|
Ìý
|
Equity instruments other than options, nonvested, number |
73,000
|
Ìý
|
Ìý
|
Restricted stock weighted average grant-date fair value |
$ 27.31
|
Ìý
|
Ìý
|